Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome
Conditions
Keywords
G1D, Glut1 Deficiency, Glucose Transporter Type 1 Deficiency, Glucose Transporter Type I Deficiency
Brief summary
This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.
Detailed description
Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.
Interventions
Sponsors
Eligibility
Inclusion criteria
* Patients enrolled in the pilot trial (UTSW 122010-186)
Exclusion criteria
* Subjects who did not complete the pilot trial (UTSW 122010-186)
Countries
United States